Elucidating substrate promiscuity in the human cytochrome 3A4

Area of Science:

• Biochemistry
• Pharmacology
• Computational Chemistry

Background:

• Human cytochrome P450 enzymes (CYPs) are crucial for metabolizing xenobiotics and endogenous compounds.
• CYPs, particularly CYP 3A4, significantly impact drug bioavailability and toxicity, presenting challenges in drug development.
• CYP 3A4 metabolizes over one-third of all prescribed drugs.

Purpose of the Study:

• To investigate the drug metabolism capabilities of CYP 3A4 using ensemble-docking simulations.
• To assess the accuracy of predicting drug metabolism sites and efficacy using various docking algorithms and scoring functions.
• To explore the influence of enzyme conformation, crystallographic waters, ligand properties, and stabilizing residues on docking performance.

Main Methods:

• Ensemble-docking experiments were performed on a library of 195 substrates against CYP 3A4.
• Induced fit and GOLD docking algorithms were employed with multiple scoring functions.
• Docking was conducted using three available CYP 3A4 crystal structures, with and without crystallographic waters.
• Resultant poses were evaluated based on the accuracy of predicting the site of metabolism.

Main Results:

• Analyses revealed specific residues that form favorable interactions with bound substrates.
• Utilizing multiple receptor conformations improved the accuracy of catalytic site prediction.
• Ligand size and flexibility were found to influence docking performance.
• The inclusion of crystallographic waters did not consistently enhance docking performance.

Conclusions:

• Computational docking, especially with multiple enzyme conformations, can accurately predict CYP-mediated drug metabolism.
• Understanding ligand-enzyme interactions and properties is key to optimizing docking predictions.
• This approach aids in predicting drug bioavailability and toxicity, facilitating safer and more effective drug development.